Form 4 · Filed May 21, 2026, 10:26 PM UTC
NKTR/NEKTAR THERAPEUTICS
Zalevsky Jonathan — Chief R&D Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 19, 2026 | S | sell | 199 | $66 | $13,036 | 20,975 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-235030